<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00326976</url>
  </required_header>
  <id_info>
    <org_study_id>FX06AQ-II-01</org_study_id>
    <nct_id>NCT00326976</nct_id>
  </id_info>
  <brief_title>Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury</brief_title>
  <official_title>A Multicenter, Double Blind, Randomized, Placebo Controlled Study to Measure the Effect of FX06 (a Fibrin Derived Peptide Bbeta15-42) on Ischemia Reperfusion Injury in Patients Undergoing Primary Percutaneous Coronary Intervention (PCI): The &quot;F.I.R.E.&quot; Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fibrex Medical Research &amp; Development GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fibrex Medical Research &amp; Development GmbH</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate whether FX06 is capable of limiting infarct size
      following balloon catheterization for acute myocardial infarction.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2006</start_date>
  <completion_date type="Actual">November 2007</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Infarct size as measured by cardiac MRI</measure>
    <time_frame>5-7 days post intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Myocardial scar mass and left ventricular function</measure>
    <time_frame>4 months post intervention</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">234</enrollment>
  <condition>Myocardial Ischemia</condition>
  <condition>Coronary Disease</condition>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>400 mg injected in 2 divided boluses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Matching placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>FX06</intervention_name>
    <description>400 mg as intravenous injection in two divided boluses</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutaneous coronary intervention</intervention_name>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who have given informed consent

          -  Patients after primary percutaneous coronary intervention (PCI) for acute ST-elevation
             myocardial infarction (STEMI)

          -  Men or women with no child bearing potential

          -  Onset of symptoms to balloon time &lt; 6 hours

          -  ST-elevation of at least 2 mm in at least 3 leads on 12-lead electrocardiogram (ECG)

          -  Primary PCI indicated per standard of care

          -  First myocardial infarction (MI)

          -  Single index lesion with complete occlusion [thrombolysis in myocardial infarction
             (TIMI) flow 0/I] of one target vessel.

        Exclusion Criteria:

          -  History of MI (from patient history, or from ECG)

          -  Chest pain or other angina symptoms in the 24 hours before the first recognized
             symptoms of the acute myocardial infarction (AMI)

          -  Need for coronary artery bypass graft (CABG)

          -  Administration of any thrombolytic agent since onset of AMI symptoms

          -  Serious procedural complications (e.g., procedural unintended occlusion of coronary
             artery branch, cardiac tamponade, emergency bypass operation, LM dissection, etc.)

          -  Presence of cardiogenic shock: hemodynamically unstable and/or need for positive
             inotropic agents

          -  Contraindication to cardiovascular magnetic resonance (CMR): claustrophobia,
             pacemakers, defibrillators and other electronic devices, and metallic cerebral clips;
             frequent extrasystoles (&gt; 12/Min) or atrial fibrillation (AF).

          -  Known renal dysfunction defined as serum creatinine &gt; 250 µmol/l

          -  Previous CABG

          -  History of congestive heart failure (CHF)

          -  Body mass index (BMI) &gt; 35

          -  Patients who cannot communicate reliably with the investigator

          -  Patients who are unlikely to cooperate with the requirements of the study

          -  Patients who are unwilling and/or unable to give informed consent

          -  Patients at increased risk of death from a pre-existing concurrent illness

          -  Patients participating in another clinical study

          -  Patients who have used any other investigational drugs within 1 month of first dosing

          -  Patients who have participated already in this study

          -  Patients who are employees at the investigational site; relatives or spouse of the
             investigator.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dan Atar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aker University Hospital, Oslo, Norway</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Allgemeines Krankenhaus Wien</name>
      <address>
        <city>Vienna</city>
        <zip>A-1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wilhelminen-Spital</name>
      <address>
        <city>Vienna</city>
        <zip>A-1171</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Academisch Ziekenhuis van de vrije Universiteit</name>
      <address>
        <city>Brussels</city>
        <zip>B-1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cliniques Universitaires St-Luc</name>
      <address>
        <city>Brussels</city>
        <zip>B-1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>I. Interna Klinika, Fakultni nemocnice Hradec Kralove</name>
      <address>
        <city>Hradec Kralove</city>
        <zip>CZ-50005</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologicke oddeleni, Masarykova nemocnice</name>
      <address>
        <city>Usti nad Labem</city>
        <zip>40013</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Amtssygehuset i Gentofte</name>
      <address>
        <city>Hellerup</city>
        <zip>DK-2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Aachen</name>
      <address>
        <city>Aachen</city>
        <zip>D-52057</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zentralkliniken Bad Berka</name>
      <address>
        <city>Bad Berka</city>
        <zip>D-99437</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charite, Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <zip>D-12200</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vivantes Klinikum Neukölln, Klinik für Innere Medizin</name>
      <address>
        <city>Berlin</city>
        <zip>D-13436</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ev. Freikirchliches KH Bernau und Herzzentrum Brandenburg</name>
      <address>
        <city>Bernau</city>
        <zip>D-16321</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Düren gem. GmbH, Innere I (Kardiologie)</name>
      <address>
        <city>Düren</city>
        <zip>D-52351</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Freiburg - Innere Medizin III</name>
      <address>
        <city>Freiburg</city>
        <zip>D-79106</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Martha-Maria Halle-Dölau - Innere Medizin I</name>
      <address>
        <city>Halle</city>
        <zip>D-06120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Martin-Luther-Universität Halle-Wittenberg, Klinikum der Medizinischen Fakultät, Inner Medizin III</name>
      <address>
        <city>Halle</city>
        <zip>D-06120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig-Holstein-Klinik f. Kardiologie</name>
      <address>
        <city>Kiel</city>
        <zip>D-24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universität Leipzig, Klinik für Innere Medizin, Herzzentrum</name>
      <address>
        <city>Leipzig</city>
        <zip>D-04289</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig-Holstein,Medizinische Klinik II, Campus Lübeck</name>
      <address>
        <city>Lübeck</city>
        <zip>D-23538</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Mannheim, I. Medizinische Klinik</name>
      <address>
        <city>Mannheim</city>
        <zip>D-66167</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Deutsches Herzzentrum München</name>
      <address>
        <city>Munich</city>
        <zip>D-80636</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik für Innere Medizin und Kardiologie, Marienhospital Osnabrück, Akademisches Lehrkrankenhaus der Medizinischen Hochschule Hannover</name>
      <address>
        <city>Osnabrück</city>
        <zip>D-49074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vilnius University Hospital &quot;Santariskiu klinikos&quot;, Center of Cardiology and Angiology</name>
      <address>
        <city>Vilnius</city>
        <zip>08661</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Onze Lieve Vrouwe Gasthuis</name>
      <address>
        <city>Amsterdam</city>
        <zip>NL-1091AC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Antonius Ziekenhuis</name>
      <address>
        <city>Nieuwegein</city>
        <zip>NL-3430 EM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krakowski Szpital Specjalistyczny im. Jana Pawla II</name>
      <address>
        <city>Krakow</city>
        <zip>PL-02507</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zaklad Szybkiej Diagnostyki, Kardiologicznej, Szpital im. Biekalskiego</name>
      <address>
        <city>Lodz</city>
        <zip>91-347</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczy, Zaklad Opieki Zrowotnej, Uniwersytecki Szpital Kliniczny Nr. 3, Im. dr Seweryna Sterlinga</name>
      <address>
        <city>Lodz</city>
        <zip>91-425</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute for Cardiovascular Disease</name>
      <address>
        <city>Timisoara</city>
        <zip>300310</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska Universitetssjukhuset</name>
      <address>
        <city>Gothenburg</city>
        <zip>S-41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitetssjukhuset</name>
      <address>
        <city>Linkoeping</city>
        <zip>S-58185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätshospital Zürich</name>
      <address>
        <city>Zurich</city>
        <zip>CH-8006</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Czech Republic</country>
    <country>Denmark</country>
    <country>Germany</country>
    <country>Lithuania</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Romania</country>
    <country>Sweden</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>December 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 16, 2006</study_first_submitted>
  <study_first_submitted_qc>May 16, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 17, 2006</study_first_posted>
  <last_update_submitted>December 3, 2007</last_update_submitted>
  <last_update_submitted_qc>December 3, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2007</last_update_posted>
  <responsible_party>
    <name_title>Dr: Rainer Henning</name_title>
    <organization>Fibrex Medical Research &amp; Development GmbH</organization>
  </responsible_party>
  <keyword>Angioplasty, Transluminal, Percutaneous Coronary</keyword>
  <keyword>Myocardial Revascularization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Reperfusion Injury</mesh_term>
    <mesh_term>Myocardial Reperfusion Injury</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

